Growing Awareness for Cosmetic Procedures Drives the Demand for Dermal Fillers Market

Cosmetic surgery remains to grow in popularity in developed regions, inspired by the impressive physical transformations of reducing fine lines and wrinkles by adding volume and fullness to the face. Cosmetic processes awareness in the developed nations has been augmented by several campaign advertisements, provocative television shows, and awareness programs, illustrating to advocate and empower cosmetic procedures. As a result, growing awareness of cosmetic procedures will likely be a driver for the global dermal fillers market.

Access Full Report at https://www.databridgemarketresearch.com/reports/global-dermal-fillers-market

Data Bridge Market Research analyses that the dermal fillers market is expected to reach USD 6085.69 million by 2030 from USD 2659.85 million in 2022, growing with the healthy CAGR of 10.90% in the forecast period of 2023 to 2030. Growing demand for anti-aging procedures and the rising popularity of minimally invasive aesthetics or non-surgical procedures will provide potential opportunities for the market growth in the forecast period.

Dermal Fillers Market

Rising demand for anti-aging procedures is expected to drive the market's growth rate

Skin aging is a part of a natural human aging mosaic which has become tracks and clear dissimilar trajectories in dissimilar tissues, cells and organs with a period. This is a multifaceted biological procedure prejudiced combination of intrinsic or endogenous (cellular metabolism, metabolic, genetics, and hormone processes) and exogenous or extrinsic (pollution, chemicals, ionizing radiation, chronic light exposure, toxins) factors. These aspects lead to structural progressive changes, alterations, and cumulative physiological changes in each skin layer. In contrast to atrophic and thin, dry, wrinkled, premature photo-aged skin and intrinsically aged skin normally shows a mottled discoloration, thickened epidermis, laxity, deep wrinkles, dullness, and roughness. Gradual skin elasticity loss leads to the sagging phenomenon by decreasing the speed of epidermal turnover rate, less effective desquamation and cell cycle enlargement coincides with a slower healing process. The process makes humans older, dried & thinner; skin gets less elastic and becomes incapable to protect itself from damages that lead to wrinkles, creases and lines on the skin surface. To lessen aging affects, the people use anti-aging drugs which has augmented anti-aging drugs demand all over the world.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2021

Historic Years

2020 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Biodegradable Dermal Fillers, Non-Biodegradable Dermal Fillers), Material Type (Natural Dermal Fillers, Synthetic Dermal Fillers), Application (Face Lift, Rhinoplasty, Reconstructive Surgery, Facial Line Correction, Lip Enhancement, Sagging Skin, Cheek Depression, Skin Smoothing, Dentistry, Aesthetic Restoration, Lip Plum, Scar Treatment, Chin Augmentation, Lipoatrophy Treatment, Earlobe Rejuvenation and Others), Drug Type (Branded, Generic), End User (Dermatology Clinics, Ambulatory Surgical Centers, Hospitals, Academic Research Institutes And Others), Distribution Channel (Direct Tender, Drug Stores, Retail Pharmacy, Online Pharmacy and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Suneva Medical inc (U.S.), Sinclair (U.S.), Revance (U.S.), BioPlus Co., Ltd. (South Korea), Zhejiang Jingjia Medical Technology Co.,Ltd. (China), Galderma Laboratories (U.S.), Allergan (Ireland), Merz North America, Inc (U.S.), Prollenium Medical Technologies (Canada), Contura International Ltd (Denmark), FillMed Laboratories (France), Anika Therapeutics, Inc (U,S.), Ipsen Pharma (France), BIOXIS Pharmaceuticals (U.S.), Zimmer Aesthetic (Germany), Medytox (South Korea), Shanghai Reyoungel Medical Technology Company Limited (China), Humedix (South Korea),  Croma-Pharma GmbH (South Korea), Sinclair Pharma (U.K.), Teoxane (Switzerland), Amalian (U.S.), Givaudan (Switzelansd), Mesoestetic (Spain), Sosum Global (South Korea), DSM (Netherland), IBSA Nordic ApS (Denmark), among others.

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The dermal fillers market is segmented on the basis of product type, material type, drug type, application, end user and distribution channel.

  • On the basis of type, the market is segmented into semi-permanent dermal filler, permanent dermal filler.

The semi-permanent dermal fillers segment of type segment is anticipated to dominate the dermal fillers market

Semi-permanent dermal fillers segment is expected to dominate the global dermal fillers market and is expected to reach USD 6,314.63 million by 2030 in the forecast period of 2023 to 2030  because they are mostly used in wrinkles and lip enhancement, facial line improvement application areas among others owing to long lasting, bio-absorbent and less side effects properties.

  • On the basis of product type, the market is segmented into biodegradable dermal fillers, non-biodegradable dermal fillers. Biodegradable dermal fillers segment is expected to dominate the global dermal fillers market and is expected to reach USD 5432.67 million by 2030 in the forecast period of 2023 to 2030. These products are more preferred than the non-biodegradable fillers due to safety concerns. If any problems arise after the biodegradable injection administration, these will disappear naturally.
  • On the basis of material type, the market is segmented into natural dermal fillers and synthetic dermal fillers.

The natural dermal fillers segment of material type segment is anticipated to dominate the dermal fillers market

Natural dermal fillers segment is expected to dominate the global dermal fillers market and is expected to reach USD 5350.39 million by 2030 in the forecast period of 2023 to 2030 owing have minor possibilities of allergic reaction and side effects. These dermal fillers have high compatibility with human body which can be simply removed after filler removal processes.

  • On the basis of drug type, the market is segmented into branded, generic. Natural dermal fillers segment is expected to dominate the global dermal fillers market and is expected to reach USD 6076.42 million by 2030 in the forecast period of 2023 to 2030 because extremely competitive markets are inhibiting the generic version of drugs. Also, physicians recommends the branded drugs due to high incentives of the product. As a result, the demand for branded medicine increases and dominates the market.
  • On the basis of application, the market is segmented into facial line correction, face lift, scar treatment, lip enhancement, wrinkles, sagging skin, rhinoplasty, cheek depression, dentistry, reconstructive surgery, aesthetic restoration, others. Facial line correction segment is expected to dominate the global dermal fillers market and is expected to reach USD 2259.063 million by 2030 in the forecast period of 2023 to 2030 owing to higher process volume than other application. Moreover, the growing awareness regarding the advantages of dermal filler and the augmented spending of healthcare on an aesthetic non-surgical process also increase the demand for the dermal filler in the forecast period.
  • On the basis of end user, the market is segmented into dermatology clinics, ambulatory surgical centers, hospitals and others. Dermatology clinics segment is expected to dominate the global dermal fillers market and is expected to reach USD 5080.86 million by 2028 in the forecast period of 2023 to 2030 because redundant aesthetic procedures are highly performed in dermatology clinics. Furthermore, an increasing number of specialized dermatology clinics in emergent nations are also surging the volume of the process, driving the market growth.
  • On the basis of distribution channel, the market is segmented into retail pharmacy, drug stores, and online pharmacies. Drug stores segment is expected to dominate the global dermal fillers market and is expected to reach USD 5742.152 million by 2030 in the forecast period of 2023 to 2030 due to easy availability as compared to other distribution channels and large number of drugs is obtained in direct and bulk form.

Major Players

Data Bridge Market Research recognizes the following companies as the major dermal fillers market players in dermal fillers market Suneva Medical inc (U.S.), Sinclair (U.S.), Revance (U.S.), BioPlus Co., Ltd. (South Korea), Zhejiang Jingjia Medical Technology Co.,Ltd. (China), Galderma Laboratories (U.S.), Allergan (Ireland), Merz North America, Inc (U.S.), Prollenium Medical Technologies (Canada), Contura International Ltd (Denmark),.

Dermal Fillers Market

Market Development

  • In April 2022, Sinclair Pharma announced that the company received a European CE mark for Perfectha Lidocaine in treating facial contouring, volume restoration, and wrinkle correction.
  • In November 2021, Galderma announced that it had signed a contract to acquire ALASTIN Skincare, Inc. This specialty aesthetics company is dedicated to developing clinically-tested physician-dispensed skincare products. This acquisition is subject to necessary regulatory approvals and customary closing conditions.
  • In October 2020, Allergan Aesthetics, an AbbVie company, announced that it had entered into a contract with Luminera, a privately held esthetics company based in Israel. According to this agreement, Allergan Aesthetics has acquired Luminera's full dermal filler R&D pipeline and portfolio, further enhancing its leading dermal filler portfolio.
  • In May 2020, Restylane received approval for Restylane Kysse from the U.S. FDA. It is a lip filler which has designed to increase the lips' volume, color, and texture. Restylane Kysse lasts is high in demand for lip enhancement.

Regional Analysis

Geographically, the countries covered in the dermal fillers market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

As per Data Bridge Market Research analysis:

North America is the dominant region in dermal fillers market during the forecast period 2023 to 2030

North America dominates the dermal fillers market owing to the growing prevalence of non-surgical or minimally invasive procedures. Moreover, The U.S. is anticipated to dominate the dermal fillers market owing to exponential usage of minimally invasive surgery for skin treatments in this country. Also, high consumption rate of the fillers and large availability of dermal fillers will likely boost the market's growth in this region.

Asia-Pacific is estimated to be the fastest-growing region in dermal fillers market the forecast period 2023 to 2030

Asia-Pacific is expected to grow during the forecast period of 2023 to 2030 due to the growing population and enhanced technological advancements in this region. Moreover, the growing availability of dermal fillers due to the upsurge in demand for scar and anti-aging treatment applications will likely boost the market's growth in this region.

For more detailed information about dermal fillers market report, click here – https://www.databridgemarketresearch.com/reports/global-dermal-fillers-market